Physician profile
Steven S Farber
NPI 1336131382
$22,045.63
in general payments reported to CMS, 2019-2025
48 companies · $5,072 in 2025
The $5,072 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,914 · 2020: $1,903 · 2021: $1,974 · 2022: $2,252 · 2023: $1,782 · 2024: $7,150 · 2025: $5,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,264 · Education: $5,929 · Travel and Lodging: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,263.83 |
| Education | $5,928.58 |
| Travel and Lodging | $811.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,327.23 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,342.09 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,981.18 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $1,275.43 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Insmed, INC. | $894.93 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $894.20 | 2019-2025 | Jascayd, Ofev |
| Mallinckrodt Hospital Products INC. | $849.36 | 2021-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $779.33 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $765.26 | 2019-2025 | Prolastin-C Liquid, Xembify |
| United Therapeutics Corporation | $734.61 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Genzyme Corporation | $615.90 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $343.19 | 2019-2025 | Winrevair, Keytruda |
| Verona Pharma, INC. | $318.25 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $311.07 | 2019-2024 | Yupelri |
| Baxter Healthcare | $298.06 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $290.48 | 2019-2025 | |
| Philips North America LLC | $275.13 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Gilead Sciences, INC. | $254.52 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $246.35 | 2019-2022 | |
| Advanced Respiratory, INC | $211.22 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $202.49 | 2020-2023 | Glassia |
| Electromed, INC. | $158.68 | 2019-2025 | Smartvest |
| Paratek Pharmaceuticals, INC. | $149.67 | 2021-2023 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $148.23 | 2019-2025 | |
| Viatris Specialty LLC | $139.60 | 2025 | Yupelri |
| Genentech USA, INC. | $109.64 | 2019-2021 | |
| Amgen INC. | $107.21 | 2022-2025 | Tezspire, Tavneos |
| Avadel Cns Pharmaceuticals, LLC | $97.79 | 2024-2025 | Lumryz |
| Sanofi-Aventis U.S. LLC | $96.50 | 2022 | |
| Novartis Pharmaceuticals Corporation | $95.13 | 2019-2024 | |
| Pulmonx Corporation | $92.87 | 2022-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Ani Pharmaceuticals, INC. | $78.04 | 2025 | Purified Cortrophin Gel |
| Liquidia Technologies, INC. | $60.96 | 2025 | Yutrepia |
| Inogen, INC. | $58.52 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| Harmony Biosciences LLC | $56.79 | 2023-2024 | Wakix |
| E.R. Squibb & Sons, L.L.C. | $48.56 | 2020-2021 | |
| Covis Pharma Gmbh | $45.60 | 2022 | |
| Janssen Pharmaceuticals, INC | $44.97 | 2021-2022 | |
| Pfizer INC. | $44.55 | 2019-2023 | |
| Shire North American Group INC | $39.98 | 2019 | |
| Sunovion Pharmaceuticals INC. | $35.70 | 2019 | |
| Shionogi INC | $21.66 | 2021 | |
| Vapotherm INC | $20.91 | 2022 | |
| Siemens Medical Solutions USA, INC. | $19.45 | 2024 | Cios Spin |
| 3b Medical, INC. | $17.60 | 2025 | Luna |
| Inspire Medical Systems, INC. | $16.46 | 2025 | Inspire |
| Circassia INC. | $15.79 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Farber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.